التفاصيل البيبلوغرافية
العنوان: |
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial |
المؤلفون: |
Yu, Shengyuan, Kim, Byung-Kun, Guo, Aihong, Kim, Man-Ho, Zhang, Mingjie, Wang, Zhen, Liu, Jianguang, Moon, Heui-Soo, Tan, Ge, Yang, Qian, McGrath, Donnie, Hanna, Michael, Stock, David A, Gao, Yanfei, Croop, Robert, Lu, Zhihong |
المصدر: |
The Lancet Neurology ; volume 22, issue 6, page 476-484 ; ISSN 1474-4422 |
بيانات النشر: |
Elsevier BV |
سنة النشر: |
2023 |
المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
مصطلحات موضوعية: |
Neurology (clinical) |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1016/s1474-4422(23)00126-6 |
الإتاحة: |
https://doi.org/10.1016/s1474-4422Test(23)00126-6 https://api.elsevier.com/content/article/PII:S1474442223001266?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1474442223001266?httpAccept=text/plainTest |
حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
رقم الانضمام: |
edsbas.98E498EF |
قاعدة البيانات: |
BASE |